Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
5 |
9
|
2012 |
2019 |
Blood Pressure
|
phenotype |
|
Organism Function
|
109
|
220
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Polysomnography
|
phenotype |
|
Diagnostic Procedure
|
119
|
249
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
1 |
7
|
2012 |
2012 |
Hematocrit procedure
|
phenotype |
|
Laboratory Procedure
|
138
|
216
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
4
|
2012 |
2012 |
Lipids measurement
|
group |
|
Laboratory Procedure
|
27
|
53
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Mean Corpuscular Volume (result)
|
phenotype |
|
Laboratory or Test Result
|
269
|
549
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Corpuscular Hemoglobin Concentration Mean
|
phenotype |
|
Laboratory or Test Result
|
401
|
4389
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Pseudocholinesterase Measurement
|
phenotype |
|
Laboratory Procedure
|
39
|
568
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Decreased LDL cholesterol concentration
|
phenotype |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Finding
|
9
|
|
0.100 |
None |
|
0 |
|
|
|
HYPERTRIGLYCERIDEMIA, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
3
|
0.100 |
None |
|
0 |
3
|
|
|
Decreased HDL cholesterol concentration
|
phenotype |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Finding
|
12
|
2
|
0.100 |
None |
|
0 |
|
|
|
Precocious atherosclerosis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
9
|
|
0.100 |
None |
|
0 |
|
|
|
Increased VLDL cholesterol concentration
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Serum triglycerides increased
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
5
|
6
|
0.100 |
None |
|
0 |
1
|
|
|
Atheroeruptive xanthoma
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Hyperchylomicronemia
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
2
|
2
|
0.100 |
None |
|
0 |
|
|
|
Impaired glucose tolerance
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
596
|
81
|
0.100 |
None |
|
0 |
|
|
|
Hypopituitarism
|
disease |
Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
69
|
4
|
0.100 |
None |
|
0 |
|
|
|
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.090 |
None |
1.000 |
9 |
4
|
2004 |
2017 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.090 |
None |
1.000 |
9 |
3
|
2004 |
2018 |
Cerebrovascular accident
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1658
|
591
|
0.080 |
None |
1.000 |
8 |
2
|
2006 |
2019 |
Hyperlipoproteinemia Type I
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
36
|
64
|
0.080 |
None |
1.000 |
8 |
2
|
2005 |
2019 |